Drug Pricing
Commentary
Here’s an idea for controlling drug prices: Restore market forces
By Henry I. Miller, M.S., M.D. and Jeff Stier Trump administration officials keep searching for solutions to rising prescription drug prices, which are increasing faster than inflation. “Drug makers and companies are not living up to their commitments on pricing. Not being fair to the consumer, or to our Country!” ...
Commentary
Progressives’ Prescription Drug Plan Puts Patients At Risk
In mid-January, three Democrats — Vermont Sen. Bernie Sanders, Maryland Rep. Elijah Cummings, and California Rep. Ro Khanna — introduced legislation that aims to reduce prescription drug prices. Their plan would essentially peg U.S. drug prices to those in five foreign countries where prices are typically lower because their governments forcibly control ...
Commentary
Imposing price controls on prescription drugs
President Donald Trump and Sen. Bernie Sanders don’t agree on much. But they both believe in price controls. Both men recently introduced separate proposals to impose price controls on prescription drugs. Though both men are likely well-intentioned, their plans are deeply misguided. Both proposals would discourage drug research and reduce ...
Commentary
Health spending in US is finally slowing: Here’s why
America’s health bill appears to be moderating, and market forces deserve the credit for this good news. National health expenditures grew more slowly in 2017 than in 2016, according to a report from the Centers for Medicare and Medicaid Services. The CMS statistics break down cost increases by category. Private health insurance spending grew ...
California
Governor Newsom’s troubling first act on medications
In one of his first acts, Governor Newsom signed an executive order that will change how medicines are purchased in California. With visions of big-box store discounts dancing in his head, Governor Newsom has established a bulk program that will now purchase drugs for the state’s Medicaid program (Medi-Cal). The ...
Commentary
A Market-Based Solution to Rising Drug Prices: More Competition
By Henry I. Miller, M.S., M.D. and John J. Cohrssen President Trump and high-ranking officials in his administration, including Health and Human Services Secretary Alex Azar, Council of Economic Advisers Chairman Kevin Hassett and acting White House chief of staff Mick Mulvaney, are scheduled to meet tomorrow for a strategy ...
Commentary
New Study Championing Medicare for All Is Bogus
Sen. Bernie Sanders’ 2017 Medicare for All bill (S.1804) would guarantee exceptional care to all Americans while reducing health spending by $5.11 trillion. At least that’s what a new study from researchers at the University of Massachusetts-Amherst’s Political Economy Research Institute, which is co-directed by Professor Robert Pollin, claims. Sound too good ...
Business & Economics
Drug Prices That Matter
Too often, drug pricing analyses do not shed light on how much drug expenditures are actually increasing because these studies examine the wrong price. The latest iteration is an analysis by Rx Savings Solutions. According to the Wall Street Journal, Rx Savings Solutions documented that dozens of drug makers raised the ...
Commentary
Bernie Sanders’ drug price controls would stifle medical innovation
Sen. Bernie Sanders, I-Vt., and Rep. Ro Khanna, D-Calif., recently proposed bills that would impose price controls on prescription drugs. The legislation would require pharmaceutical companies to sell their medicines in the United States for no more than the median price charged in five countries – Canada, the United Kingdom, France, Germany, ...
Commentary
After Midterms, Democrats Inch Toward Government-Run Health Care
The midterm elections were good to Democrats. They took the majority in the U.S. House and captured several state legislatures. Public frustration with health care was a big reason why. Just before the election, seven in 10 voters said that the issue was “very important” when deciding whom to vote ...
Here’s an idea for controlling drug prices: Restore market forces
By Henry I. Miller, M.S., M.D. and Jeff Stier Trump administration officials keep searching for solutions to rising prescription drug prices, which are increasing faster than inflation. “Drug makers and companies are not living up to their commitments on pricing. Not being fair to the consumer, or to our Country!” ...
Progressives’ Prescription Drug Plan Puts Patients At Risk
In mid-January, three Democrats — Vermont Sen. Bernie Sanders, Maryland Rep. Elijah Cummings, and California Rep. Ro Khanna — introduced legislation that aims to reduce prescription drug prices. Their plan would essentially peg U.S. drug prices to those in five foreign countries where prices are typically lower because their governments forcibly control ...
Imposing price controls on prescription drugs
President Donald Trump and Sen. Bernie Sanders don’t agree on much. But they both believe in price controls. Both men recently introduced separate proposals to impose price controls on prescription drugs. Though both men are likely well-intentioned, their plans are deeply misguided. Both proposals would discourage drug research and reduce ...
Health spending in US is finally slowing: Here’s why
America’s health bill appears to be moderating, and market forces deserve the credit for this good news. National health expenditures grew more slowly in 2017 than in 2016, according to a report from the Centers for Medicare and Medicaid Services. The CMS statistics break down cost increases by category. Private health insurance spending grew ...
Governor Newsom’s troubling first act on medications
In one of his first acts, Governor Newsom signed an executive order that will change how medicines are purchased in California. With visions of big-box store discounts dancing in his head, Governor Newsom has established a bulk program that will now purchase drugs for the state’s Medicaid program (Medi-Cal). The ...
A Market-Based Solution to Rising Drug Prices: More Competition
By Henry I. Miller, M.S., M.D. and John J. Cohrssen President Trump and high-ranking officials in his administration, including Health and Human Services Secretary Alex Azar, Council of Economic Advisers Chairman Kevin Hassett and acting White House chief of staff Mick Mulvaney, are scheduled to meet tomorrow for a strategy ...
New Study Championing Medicare for All Is Bogus
Sen. Bernie Sanders’ 2017 Medicare for All bill (S.1804) would guarantee exceptional care to all Americans while reducing health spending by $5.11 trillion. At least that’s what a new study from researchers at the University of Massachusetts-Amherst’s Political Economy Research Institute, which is co-directed by Professor Robert Pollin, claims. Sound too good ...
Drug Prices That Matter
Too often, drug pricing analyses do not shed light on how much drug expenditures are actually increasing because these studies examine the wrong price. The latest iteration is an analysis by Rx Savings Solutions. According to the Wall Street Journal, Rx Savings Solutions documented that dozens of drug makers raised the ...
Bernie Sanders’ drug price controls would stifle medical innovation
Sen. Bernie Sanders, I-Vt., and Rep. Ro Khanna, D-Calif., recently proposed bills that would impose price controls on prescription drugs. The legislation would require pharmaceutical companies to sell their medicines in the United States for no more than the median price charged in five countries – Canada, the United Kingdom, France, Germany, ...
After Midterms, Democrats Inch Toward Government-Run Health Care
The midterm elections were good to Democrats. They took the majority in the U.S. House and captured several state legislatures. Public frustration with health care was a big reason why. Just before the election, seven in 10 voters said that the issue was “very important” when deciding whom to vote ...
